tykhr
sign in
free sign up
The Valens Company, Inc. Common Shares
Drug Manufacturers-Specialty & Generic
Healthcare
VLNS
61.66M shares
NASDAQ US
traded
08 Apr 2022
listed
yes
open
1.33
52 week high
5.02
high
1.38
52 week low
1.35
low
1.27
growth
-52.63%
previous Close
1.36
P/E ratio
-7
market cap
139M
div yield
0
usd
Aug 2021
qoq
revenue
20.99M
net incoming
-12.80M
eps
-0.18
0.00 %
eps surprise
0.00 %
net profit margin
-60.98 %
-60.00 %
operating incoming
-13.83M
net change in cash
7.03M
cash on hand
30.96M
cost of revenue
15.36M
top